Cue Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 526 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 326-350 of 526 matching filings.

Per page
25
Current page
14
424B5 File 333-239357

424B5

Filing date
22 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-239357

S-3ASR

Filing date
22 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
05 Jun 2020
Reporting date
04 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38327

DEFA14A

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38327

DEF 14A

Filing date
29 May 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
19 May 2020
Reporting date
19 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38327

PRE 14A

Filing date
15 May 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38327

CUE-Q1-2020

Filing date
07 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
10-K/A File 001-38327

10-K/A

Filing date
29 Apr 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90232

SC 13D/A filing

Filing date
21 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
27 Mar 2020
Reporting date
27 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-229140

424B5

Filing date
27 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Mar 2020
Reporting date
24 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
17 Mar 2020
Reporting date
17 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-237140

S-8

Filing date
12 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-38327

10-K/A

Filing date
12 Mar 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

8-K

Filing date
02 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
24 Feb 2020
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90232

SC 13G

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90232

CUE BIOPHARMA, INC.

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Feb 2020
Reporting date
05 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Feb 2020
Reporting date
05 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .